FDA Risk-Based Part 11 Proposal Expected By February 2003
This article was originally published in The Tan Sheet
Executive Summary
FDA intends to issue a policy statement on how its risk-based Good Manufacturing Practices initiative will affect 21 CFR Part 11 - the electronic records and electronic signatures reg - by early next year